Traditional MedicareCoverageMedium impact
New Medicare Pilot Program for GLP-1 Starts July 1
EmblemHealth·Endocrinology, Bariatric Surgery, Family Medicine +2 more·Provider News
Effective date
Jul 1, 2026
We identified it
Jul 17, 2026
Summary
Medicare is launching a temporary GLP-1 Bridge program effective July 1, 2026, covering weight loss and weight management medications for eligible Medicare Part D beneficiaries through December 31, 2027. EmblemHealth plans may also cover GLP-1 medications for members with diabetes and other clinical criteria. Billing teams must verify coverage, obtain prior authorization per plan requirements, and track the temporary program end date to avoid claim denials.
Action Required
By June 15, 2026: Billing team must contact EmblemHealth and Medicare to obtain specific prior authorization requirements and coverage criteria for GLP-1 medications under the Medicare GLP-1 Bridge program. Update billing system with new authorization workflows for GLP-1 prescriptions and create a flag for claims to expire on December 31, 2027. Providers should document clinical criteria (weight loss, weight management, diabetes, or other qualifying conditions) on all GLP-1 claims. Front desk staff must add a checklist to patient intake forms to identify Medicare beneficiaries requesting GLP-1 medications. Verify coverage status with each payer before claim submission. Without prior authorization, claims will be denied and patients may face unexpected out-of-pocket costs.